64 results
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
28 Mar 24
Can-Fite Reports 2023 Financial Results and Clinical Update
7:05am
was offset by the Company’s financing during January 2023 and exercise of certain warrants during November 2023.
The Company’s consolidated financial
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
30 Nov 23
Can-Fite Reports Third Quarter 2023 Financial Results and Clinical Update
7:05am
30, 2023 is due to the ongoing operations of the Company which was offset by the Company’s fundraise during January 2023. During November 2023, Can
F-3
CANF
Can-Fite Biopharma Ltd
1 Sep 23
Shelf registration (foreign)
4:15pm
a filing fee of $10,119.34 after giving effect to a fee offset. In connection therewith, $84,500,000 of the securities remain unsold, leaving $10,968.10 … in previously paid fees available for future offset (calculated at the fee rate in effect on the filing date of the Prior Registration Statement
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
1 Jun 23
Can-Fite Reports First Quarter 2023 Financial Results & Provides Clinical Update
7:07am
to an increase in research and development expenses which was partly offset by an increase in finance income, net.
As of March 31, 2023, Can-Fite had … the three months ended March 31, 2023 is due to the issuance of share capital and warrants which was offset by ongoing operations of the Company
6-K
EX-99.1
xffi6dj
30 Mar 23
Can-Fite Reports 2022 Financial Results & Provides Clinical Update
7:56am
6-K
EX-99.1
c4r9fdnl5ykocloh
26 May 22
Can-Fite Reports First Quarter 2022 Financial Results & Provides Clinical Update
7:18am
6-K
EX-99.1
7p9gtnk16fi
24 Mar 22
Can-Fite Reports 2021 Financial Results & Provides Clinical Update
8:39am
6-K
EX-99.1
p7yab
26 Nov 21
Can-Fite Reports Third Quarter 2021 Financial Results & Provides Clinical Update
7:09am
6-K
EX-99.1
0f018xt5qfv
26 Aug 21
Report of Foreign Private Issuer
7:28am
6-K
EX-99.3
tz5fu5
26 Aug 21
Report of Foreign Private Issuer
7:28am
6-K
EX-99.1
st8p 58w7riun8yr
27 May 21
Can-Fite Reports First Quarter 2021 Financial Results & Provides Clinical Update
7:11am
6-K
EX-99.1
ub8ujsc57mjps1m6b
25 Mar 21
Can-Fite Reports 2020 Financial Results & Provides Clinical Development Update
8:43am
6-K
EX-99.1
fj6ff7g y4
30 Nov 20
Can-Fite Reports Third Quarter 2020 Financial Results & Provides Clinical Update
7:12am
6-K
EX-99.1
zcov1vi8p air
27 Aug 20
Report of Foreign Private Issuer
7:10am
6-K
EX-99.3
c618ri2
27 Aug 20
Report of Foreign Private Issuer
7:10am
424B3
l8ezy
1 Jun 20
Prospectus supplement
7:23am